For use by individuals with symptoms of respiratory viral infection consistent with COVID-19.
With similar symptoms for all three infections, this comprehensive test helps you determine your COVID-19, flu, and RSV status with one short swab.
It’s easy. We’ll send you an at-home collection kit to collect your nasal swab sample. Use the prepaid shipping label to send your kit back to our lab for testing. The average time to deliver results is currently 1-2 days from when your sample is received at the lab. Our labs process samples seven days a week. Check with your local FedEx for pick up and drop off locations.
Note: This test is not a rapid test—it is a PCR test. Samples are sent back to our lab.
*Labcorp OnDemand offers this test and collection kit with an FDA Emergency Use Authorization. This means that while the laboratory performing this test has validation data to support offering this test and the collection kit, neither have been approved or cleared by the FDA. This product has been authorized only for the detection and differentiation of nucleic acid from SARS-CoV-2, influenza A, influenza B and/or Respiratory Syncytial Virus (RSV), not for any other viruses or pathogens. It is only authorized during the duration of the COVID-19 emergency declaration by federal regulators. LabCorp may modify or cease to offer the test and the test kit upon direction of state or federal regulators in its sole discretion. Please see the Patient Fact Sheet and the Health Care Provider Fact Sheet for additional information.
Preparation: No special preparation is needed.
Our PCR Test detects known SARS-CoV-2 Variants, including Delta and Omicron*
PCR tests are considered a gold standard by the CDC** for diagnosing COVID-19 because of their sensitivity and specificity
Labcorp has performed over 60 million COVID-19 tests since March 2020
Our PCR test is the same test used by doctors & hospitals to detect COVID-19, FluA, FluB, and RSV
*If your test is positive for COVID-19 or flu, you may be contacted by a trusted third-party physician network (PWN) to discuss next steps.
Simply purchase this test online and we’ll ship a kit to you within 1-2 business days. A healthcare provider will review and approve your test requests; no healthcare provider visit required.
View your easy-to-read results online in your Labcorp Patient™ account, including Linked Accounts. For certain results that require prompt attention, you will also be contacted by phone or mail.
The Pixel by Labcorp® COVID-19 + Flu + RSV at-home kit is a PCR test, also known as a reverse polymerase chain reaction test or a nucleic acid amplification test (NAAT). This test detects the presence or absence of SARS-CoV-2, the virus that causes COVID-19, as well as influenza A or B, and Respiratory Syncytial Virus (RSV).
This collection kit is $129 and intended for individuals ages 2 or older looking to get tested for an active infection.
Your test results will detect whether you are infected with SARS-CoV-2, Influenza A, Influenza B and/or RSV. If your results are positive for one or more of the viruses, it is important to limit your exposure to other people and continue to monitor your symptoms. If your results are negative, the viruses were not detected in the sample you provided. However, it is important to note that the viruses may not be detected by the test in early stages of infection. Furthermore, the viruses may not be detected if the sample is not collected as directed. If you have reason to believe you have been exposed, it is important to follow up with a healthcare provider for further evaluation, get re-tested, and follow isolation or quarantine precautions as recommended.
After receiving your results, you will have the opportunity to speak with a licensed healthcare provider who can answer any questions you may have about your test results and help determine next steps in care.
If you feel like you are having a medical emergency, please call 9-1-1.
If you are experiencing severe trouble breathing; continuous pain or pressure in your chest or abdomen; feeling confused; having difficulty waking up or staying awake; pale, gray, or blue-colored skin, lips, or nail beds; seizures; being unable to urinate; severe muscle pain or weakness; fever or cough that improves but then returns or worsens; worsening of medical conditions; or any other emergency signs or symptoms, please seek immediate medical care.
If your condition changes before you are able to obtain the test or the test result, please visit your local emergency room as soon as possible.
Check out our COVID-19 FAQs for more information.
You can also find out more at the links below:
Centers for Disease Control and Prevention: Respiratory Syncytial Virus Infection (RSV)
Centers for Disease Control and Prevention: Coronavirus Disease 2019
World Health Organization: Coronavirus disease (COVID-19) pandemic
The federal Public Health Emergency (PHE) for COVID-19 which was declared under Section 319 of the Public Health Service Act, is ending at the end of the day on May 11, 2023.
Following changes to the public health emergency, the requirements for how commercial insurers must cover COVID-19 tests will change. Likewise, there are changes to requirements for government programs for coverage of this testing.
Individuals will be responsible for the full cost of COVID-19 testing at the time of purchase effective on May 12, 2023.
If you submit your test to Labcorp after May 11, 2023, and are relying on commercial insurance or a government program benefit to pay for COVID-19 testing, you may be responsible for payment for the test in accordance with their new coverage policies. To learn more about your coverage, please check with your insurance company or government program on their policy.
A separate COVID-19 PHE will remain in effect, allowing tests and other products, including vaccines, to continue to be offered. A termination date for that PHE has not yet been announced.
See Public Health Emergency Expiration FAQs for more information.
